The 3rd Annual US-China Pharma conference will focus on a variety of topics, such as how to shrewdly adapt to China’s new healthcare system and protect and profit from intellectual property, to profitably pricing and marketing brand, generic and biosimilar products.
WilmerHale Counsel Henry Gu will participate on a panel titled “Protecting and Enforcing Your Intellectual Property Rights in China.”